title: Abiraterone: current and future use in prostate cancer.
authors.affiliation: UCSF Helen Diller Family Comprehensive Cancer, San Francisco, California, USA.
authors.forename: Charles J
authors.initials: CJ
authors.lastname: Ryan
mesh_terms: D000736:Androstenes; D000737:Androstenols / Q000009:adverse effects / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D000075202:Contraindications; D017277:Drug Approval; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D000736:Androstenes; D000737:Androstenols; D018931:Antineoplastic Agents, Hormonal; D004791:Enzyme Inhibitors; C089740:abiraterone